Why do medicines that are fully paid

Medicinal products included in Appendix No. 1 of the Positive Drug List are intended for the treatment of diseases for out-of-hospital care, which are paid for by the NHIF in accordance with the Health Insurance Act. For each medicinal product, the NHIF pays a certain percentage. Medicinal products with the same international non-proprietary name are grouped according to the dosage form and indications for treatment. The health insurance fund pays 100% of the value of a package of medicinal product with the lowest price in the relevant group, the so-called referent. When in the relevant group the price of another medicinal product becomes a reference, i.e. with the lowest price, then this medicinal product, which until then was a reference and was fully paid for by the NHIF, should be paid additionally by the patient. Usually, these medicinal products are analogues and contain the same active substance, which is why they are interchangeable. In this case, it is best to consult your doctor or pharmacist.